 LONDON and RALEIGH, N.C., Aug. 31, 2021 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference. The presentation will be available on-demand starting at 7:00 AM EDT 12:00 PM BST on Monday, September 13, 2021. 